Closed End Fund Advisors Inc. purchased a new stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 36,623 shares of the company’s stock, valued at approximately $519,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Keener Financial Planning LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at about $29,000. Geneos Wealth Management Inc. increased its position in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after buying an additional 1,582 shares during the period. N.E.W. Advisory Services LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after buying an additional 1,200 shares during the period. Parallel Advisors LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at about $47,000. Finally, Brown Brothers Harriman & Co. increased its position in shares of BlackRock Capital Allocation Term Trust by 450.0% during the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after buying an additional 4,500 shares during the period. 36.12% of the stock is currently owned by institutional investors.
BlackRock Capital Allocation Term Trust Trading Down 0.9%
Shares of BCAT opened at $15.49 on Friday. The business’s 50-day moving average price is $15.10 and its 200-day moving average price is $14.77. BlackRock Capital Allocation Term Trust has a twelve month low of $13.73 and a twelve month high of $15.98.
BlackRock Capital Allocation Term Trust Profile
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
